In the News May 17, 2022

HBWInsight, Rose Sheet | Hemp Roundtable Says Safety Study Data Should Convince Congress on Lawful CBD Use

Marc Scheineson is quoted on key considerations for the Food & Drug Administration and Congress in rulemaking on the lawful use of CBD in supplements and other products.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.